Plus Therapeutics, Inc. | CYTX - Debt


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Plus Therapeutics, Inc.

Plus Therapeutics, Inc. reported $5.06M in Debt for its fiscal quarter ending in March of 2023.


Debt Change
Baxter International BAX:US USD 16.43B 205M
Cerus CERS:US USD 72.83M 3.02M
Haemonetics HAE:US USD 765.89M 889K
Northwest Biotherapeutics NWBO:US USD 26.62M 5.1M
Plus Therapeutics, Inc. CYTX:US USD 5.06M 337K
Starpharma Holdings Ltd SPL:AU AUD 7.85M 340K
Teva Pharmaceutical Industries Ltd TEVA:IT USD 20.69B 521M